» Articles » PMID: 38674628

TiO Nanocomposite Coatings and Inactivation of Carbapenemase-Producing Klebsiella Pneumoniae Biofilm-Opportunities and Challenges

Overview
Journal Microorganisms
Specialty Microbiology
Date 2024 Apr 27
PMID 38674628
Authors
Affiliations
Soon will be listed here.
Abstract

The worldwide increase of multidrug-resistant Gram-negative bacteria is a global threat. The emergence and global spread of carbapenemase- (KPC-) producing represent a particular concern. This pathogen has increased resistance and abilities to persist in human reservoirs, in hospital environments, on medical devices, and to generate biofilms. Mortality related to this microorganism is high among immunosuppressed oncological patients and those with multiple hospitalizations and an extended stay in intensive care. There is a severe threat posed by the ability of biofilms to grow and resist antibiotics. Various nanotechnology-based strategies have been studied and developed to prevent and combat serious health problems caused by biofilm infections. The aim of this review was to evaluate the implications of nanotechnology in eradicating biofilms with KPC-producing , one of the bacteria most frequently associated with nosocomial infections in intensive care units, including in our department, and to highlight studies presenting the potential applicability of TiO nanocomposite materials in hospital practice. We also described the frequency of the presence of bacterial biofilms on medical surfaces, devices, and equipment. TiO nanocomposite coatings are one of the best long-term options for antimicrobial efficacy due to their biocompatibility, stability, corrosion resistance, and low cost; they find their applicability in hospital practice due to their critical antimicrobial role for surfaces and orthopedic and dental implants. The International Agency for Research on Cancer has recently classified titanium dioxide nanoparticles (TiO NPs) as possibly carcinogenic. Currently, there is an interest in the ecological, non-toxic synthesis of TiO nanoparticles via biological methods. Biogenic, non-toxic nanoparticles have remarkable properties due to their biocompatibility, stability, and size. Few studies have mentioned the use of nanoparticle-coated surfaces as antibiofilm agents. A literature review was performed to identify publications related to KPC-producing biofilms and antimicrobial TiO photocatalytic nanocomposite coatings. There are few reviews on the antibacterial and antibiofilm applications of TiO photocatalytic nanocomposite coatings. TiO nanoparticles demonstrated marked antibiofilm activity, but being nano in size, these nanoparticles can penetrate cell membranes and may initiate cellular toxicity and genotoxicity. Biogenic TiO nanoparticles obtained via green, ecological technology have less applicability but are actively investigated.

Citing Articles

Antimicrobial Resistance Patterns and Biofilm Analysis via Sonication in Intensive Care Unit Patients at a County Emergency Hospital in Romania.

Codru I, Vintila B, Bereanu A, Sava M, Popa L, Birlutiu V Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005975 PMC: 11858300. DOI: 10.3390/ph18020161.


Optimizing Diagnosis and Management of Ventilator-Associated Pneumonia: A Systematic Evaluation of Biofilm Detection Methods and Bacterial Colonization on Endotracheal Tubes.

Codru I, Vintila B, Sava M, Bereanu A, Neamtu S, Badila R Microorganisms. 2024; 12(10).

PMID: 39458275 PMC: 11509713. DOI: 10.3390/microorganisms12101966.


Prevalence of Infections and Antimicrobial Resistance of ESKAPE Group Bacteria Isolated from Patients Admitted to the Intensive Care Unit of a County Emergency Hospital in Romania.

Bereanu A, Bereanu R, Mohor C, Vintila B, Codru I, Olteanu C Antibiotics (Basel). 2024; 13(5).

PMID: 38786129 PMC: 11117271. DOI: 10.3390/antibiotics13050400.

References
1.
Perez-Palacios P, Gual-de-Torrella A, Delgado-Valverde M, Oteo-Iglesias J, Hidalgo-Diaz C, Pascual A . Transfer of plasmids harbouring bla carbapenemase genes in biofilm-growing Klebsiella pneumoniae: Effect of biocide exposure. Microbiol Res. 2021; 254:126894. DOI: 10.1016/j.micres.2021.126894. View

2.
Reyes J, Aguilar A, Caicedo A . Carbapenem-Resistant : Microbiology Key Points for Clinical Practice. Int J Gen Med. 2019; 12:437-446. PMC: 6886555. DOI: 10.2147/IJGM.S214305. View

3.
Vitale S, Rampazzo E, Hiebner D, Devlin H, Quinn L, Prodi L . Interaction between Engineered Pluronic Silica Nanoparticles and Bacterial Biofilms: Elucidating the Role of Nanoparticle Surface Chemistry and EPS Matrix. ACS Appl Mater Interfaces. 2022; 14(30):34502-34512. DOI: 10.1021/acsami.2c10347. View

4.
Imtiaz W, Dasti J, Andrews S . Draft genome sequence of a carbapenemase-producing (NDM-1) and multidrug-resistant, hypervirulent Klebsiella pneumoniae ST11 isolate from Pakistan, with a non-hypermucoviscous phenotype associated with rmpA2 mutation. J Glob Antimicrob Resist. 2021; 25:359-362. DOI: 10.1016/j.jgar.2021.04.017. View

5.
Araujo B, Ferreira M, de Campos P, Royer S, Goncalves I, Batistao D . Hypervirulence and biofilm production in KPC-2-producing Klebsiella pneumoniae CG258 isolated in Brazil. J Med Microbiol. 2018; 67(4):523-528. DOI: 10.1099/jmm.0.000711. View